Exscientia is now Recursion
Stay up to date at www.Recursion.com
Patient-first AI
We combine high-precision information from viable patient tissue, screened in our own laboratories, with our carefully engineered AI platforms. This empowers target selection, precision design and experiment, as well as enhanced clinical assessment.
Patient Driven
We use patient tissue data to define optimal profiles for research, improve experimental assessment during design and improve outcomes in a
clinical setting.
Precision Engineering
Drug discovery is precision engineering at the molecular scale. Exscientia’s team is delivering key advances across data acquisition, machine learning and generative systems to fulfil sophisticated design objectives.
AI Platforms
Talented teams define projects and set strategic goals, while employing AI platforms to achieve tactical excellence across preclinical and clinical research.